Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Capital Increase by Subsidiary / 2024-12-30

Posted on December 30, 2024August 8, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Capital Increase by Subsidiary / 2024-12-30

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Ocean has filed a corrected disclosure updating the authorized share limit to 10,000 shares and changing the payment date to undecided (to be disclosed via amended filing once finalized) regarding the capital increase of its subsidiary (Hanwha Ocean USA Holdings Corp.).

📊 [Key Disclosure Details & Financial Highlights]

  • Correction Classification: Corrected Filing (Report)
  • Correction Filing Date: December 30, 2024
  • Original Disclosure Document & Date: Decision on Capital Increase by Subsidiary (April 19, 2024)
  • Reason for Correction: Change in payment date, revision of authorized share count
  • Major Corrected Items:
    • Share Price Determination Method (Authorized Share Limit): Determined within the limit of 5,000 authorized shares before correction → Determined within the limit of 10,000 authorized shares after correction
    • Payment Date: December 31, 2024, before correction → Undecided after correction (to be disclosed via amended filing once final completion date is fixed)
  • Subsidiary Details:
    • Subsidiary Name: Hanwha Ocean USA Holdings Corp. (CEO: Yeon-Seong Jang / Main Business: Maritime service)
    • Major Subsidiary Status: N/A (Newly incorporated in 2023)
  • Capital Increase Details:
    • Class and Number of New Shares: Common stock 1,351 shares
    • Par Value per Share: KRW 1,346 (1 USD / Exchange rate of KRW 1,345.80/USD applied)
    • Total Issued Shares Before Capital Increase: Common stock 1 share
    • Use of Proceeds by Purpose:
      • Operating Funds: KRW 134,580,000 (approx. KRW 134.6M)
      • Acquisition of Securities of Other Corporations: KRW 181,683,000,000 (approx. KRW 181.7B)
    • Capital Increase Method: Capital Increase by Shareholder Allocation (Number of new shares allocated per share: 1,351)
    • Issue Price per New Share: KRW 134,580,000 (USD 100,000)
    • Board Resolution Date: March 27, 2024 (US local time)
  • Other Important Notes:
    • Purpose is to secure operating funds and investment capital for the 100%-owned subsidiary
    • Converted KRW amounts apply the exchange rate as of March 28, 2024 (1 USD = KRW 1,345.80) and may fluctuate based on exchange rates at actual execution
    • Exempt from Securities Registration Statement requirement as a foreign unlisted entity
    • Related Disclosure: April 19, 2024 (Decision on Capital Increase by Subsidiary)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Authorized Share Limit Revision and Subsequent Filings for Confirmed Payment Date

This correction filing notifies the market that the authorized share limit for the subsidiary’s capital increase was updated to 10,000 shares and that the payment date was changed to undecided, with a corrected disclosure scheduled once the final completion date is confirmed. Verifying whether a subsequent corrected disclosure is filed with the finalized payment date is essential for tracking the actual execution progress of the initially disclosed capital increase terms. Related details can be verified in upcoming official regular filings, including Quarterly, Half-Yearly, and Annual Reports.

📢 Disclaimer & Fact Source

Source: This content was structured and newly written based on officially submitted data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Disclaimer: This material is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For regulatory compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Shipbuilding

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) Amends DAPA Contract: ‘TICN 4th Mass Production’ Value Increased to KRW 650.5B, Completion Date Extended
Next Post: [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Acquisition of Shares or Equity Securities of Other Corporations / 2024-12-30

Related Posts

[Disclosure] Jeju Semiconductor(080220) – Decision on Issuance of Bonds with Warrants (5th Series) / 2026-03-13 Semiconductors
[Disclosure] Hanmi Semiconductor (042700) – Single Sales/Supply Contract / 2026-01-14 Semiconductors
[Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-11-18 Semiconductors
[Disclosure] Hanwha Ocean (042660) – (Correction) Signing of Single Sales/Supply Contract / 2025-03-18 Disclosures
[Disclosure] Hanwha Aerospace (012450) Amends Schedule and Adjustment Formulas for Stock Futures/Options Market Measures Following Revised Capital Increase Timeline Disclosures
[Disclosure] SK Square (402340) – Share Cancellation Decision / 2025-03-27 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme